Growth Metrics

Corcept Therapeutics (CORT) Change in Cash (2010 - 2026)

Corcept Therapeutics recorded quarterly Change in Cash of -$11.8 million in Q1 2026, down 153.22% quarter-over-quarter from -$4.6 million in Q4 2025, and up 68.93% year-over-year from -$7.0 million in Q1 2025.

Corcept Therapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at -$11.8 million for Q1 2026.

  • In Q1 2026, Change in Cash rose 68.93% year-over-year to -$11.8 million; the TTM figure through Mar 2026 stood at $18.9 million (up 131.57% YoY), while the FY2025 annual figure was -$7.2 million, up 9.08% from the prior year.
  • Change in Cash came in at -$11.8 million for Q1 2026 at Corcept Therapeutics, down from -$4.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $233.6 million in Q1 2023 to a low of -$127.6 million in Q2 2023.
  • A 5-year average of $1.8 million and a median of -$4.6 million in 2025 frame the typical range for Change in Cash.
  • Across the five-year window, Change in Cash surged 2107.68% in 2022 and plunged 506.64% in 2023, its largest moves.
  • Corcept Therapeutics' Change in Cash stood at $16.1 million in 2022, then jumped by 47.65% to $23.8 million in 2023, then slumped by 140.52% to -$9.6 million in 2024, then jumped by 51.76% to -$4.6 million in 2025, then tumbled by 153.22% to -$11.8 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered -$11.8 million, -$4.6 million, and $22.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 2.44 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 623.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 417.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -153.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 53.61 Mn
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn -11.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -11.76 Mn
Dec 31, 2025 -4.64 Mn
Sep 30, 2025 22.39 Mn
Jun 30, 2025 12.93 Mn
Mar 31, 2025 -37.85 Mn
Dec 31, 2024 -9.62 Mn
Sep 30, 2024 8.70 Mn
Jun 30, 2024 -21.16 Mn
Mar 31, 2024 14.20 Mn
Dec 31, 2023 23.75 Mn
Sep 30, 2023 -60.58 Mn
Jun 30, 2023 -127.57 Mn
Mar 31, 2023 233.61 Mn
Dec 31, 2022 16.09 Mn
Sep 30, 2022 14.90 Mn
Jun 30, 2022 -26.52 Mn
Mar 31, 2022 -15.76 Mn
Dec 31, 2021 -17.07 Mn
Sep 30, 2021 -742,000.00
Jun 30, 2021 43.05 Mn
Mar 31, 2021 -23.81 Mn
Dec 31, 2020 45.63 Mn
Sep 30, 2020 -27.96 Mn
Jun 30, 2020 -25.95 Mn
Mar 31, 2020 53.21 Mn
Dec 31, 2019 -13.68 Mn
Sep 30, 2019 -13.19 Mn
Jun 30, 2019 8.49 Mn
Mar 31, 2019 8.03 Mn
Dec 31, 2018 7.73 Mn
Sep 30, 2018 2.73 Mn
Jun 30, 2018 -1.96 Mn
Mar 31, 2018 2.06 Mn
Dec 31, 2017 2,000.00
Sep 30, 2017 -2.56 Mn
Jun 30, 2017 -4.35 Mn
Mar 31, 2017 -13.56 Mn
Dec 31, 2016 3.67 Mn
Sep 30, 2016 6.08 Mn
Jun 30, 2016 1.05 Mn
Mar 31, 2016 309,000.00
Dec 31, 2015 3.99 Mn
Sep 30, 2015 -598,000.00
Jun 30, 2015 -905,000.00
Mar 31, 2015 13.71 Mn
Dec 31, 2014 -2.53 Mn
Sep 30, 2014 -7.19 Mn
Jun 30, 2014 -9.64 Mn
Mar 31, 2014 -11.26 Mn
Dec 31, 2013 -8.30 Mn
Sep 30, 2013 -9.05 Mn
Jun 30, 2013 -9.24 Mn
Mar 31, 2013 -11.57 Mn
Dec 31, 2012 -8.60 Mn
Sep 30, 2012 66.73 Mn
Jun 30, 2012 -7.73 Mn
Mar 31, 2012 2.99 Mn
Dec 31, 2011 -6.27 Mn
Sep 30, 2011 -6.32 Mn
Jun 30, 2011 -6.97 Mn
Mar 31, 2011 34.62 Mn
Dec 31, 2010 -4.40 Mn
Sep 30, 2010 -6.41 Mn